Victory Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$285M Sell
964,043
-1,085,606
-53% -$322M 0.18% 138
2025
Q4
$560M Buy
2,049,649
+1,807,491
+746% +$491M 0.32% 64
2025
Q3
$65.4M Sell
242,158
-9,840
-4% -$2.68M 0.04% 437
2025
Q2
$69.5M Buy
251,998
+28,050
+13% +$7.63M 0.04% 418
2025
Q1
$59.4M Sell
223,948
-13,005
-5% -$3.21M 0.06% 393
2024
Q4
$55M Buy
236,953
+1,339
+0.6% +$308K 0.05% 426
2024
Q3
$52M Sell
235,614
-2,583
-1% -$535K 0.05% 451
2024
Q2
$46.8M Sell
238,197
-2,278
-0.9% -$471K 0.05% 471
2024
Q1
$51.8M Buy
240,475
+26,206
+12% +$5.5M 0.05% 454
2023
Q4
$45.1M Buy
214,269
+10,497
+5% +$2.24M 0.05% 470
2023
Q3
$40.8M Sell
203,772
-22,152
-10% -$4.4M 0.05% 483
2023
Q2
$41.9M Sell
225,924
-119,879
-35% -$22.2M 0.05% 484
2023
Q1
$66.2M Buy
345,803
+27,943
+9% +$5.05M 0.07% 350
2022
Q4
$53.5M Sell
317,860
-16,315
-5% -$2.84M 0.06% 421
2022
Q3
$59.2M Buy
334,175
+39,500
+13% +$7.81M 0.07% 396
2022
Q2
$60.3M Buy
294,675
+36,016
+14% +$7.63M 0.07% 396
2022
Q1
$56.7M Buy
258,659
+38,294
+17% +$8.99M 0.06% 474
2021
Q4
$50.3M Buy
220,365
+9,375
+4% +$2.06M 0.05% 557
2021
Q3
$40.8M Buy
210,990
+5,587
+3% +$1.13M 0.04% 612
2021
Q2
$43.7M Buy
205,403
+4,301
+2% +$908K 0.04% 608
2021
Q1
$41.1M Buy
201,102
+61,039
+44% +$12M 0.04% 622
2020
Q4
$25.5M Buy
140,063
+1,878
+1% +$319K 0.03% 778
2020
Q3
$23.1M Sell
138,185
-31,543
-19% -$5.31M 0.03% 727
2020
Q2
$27.6M Sell
169,728
-262,196
-61% -$47M 0.04% 654
2020
Q1
$74.7M Sell
431,924
-145,067
-25% -$28.9M 0.06% 445
2019
Q4
$116M Sell
576,991
-12,937
-2% -$2.65M 0.14% 192
2019
Q3
$125M Buy
589,928
+434,226
+279% +$90.7M 0.16% 159
2019
Q2
$30.2M Buy
155,702
+57,635
+59% +$10.6M 0.06% 469
2019
Q1
$16.1M Buy
98,067
+64,233
+190% +$11.4M 0.04% 615
2018
Q4
$6.37M Buy
33,834
+1,416
+4% +$261K 0.02% 784
2018
Q3
$5.52M Sell
32,418
-62,367
-66% -$10.5M 0.01% 842
2018
Q2
$15.5M Sell
94,785
-176
-0.2% -$28.7K 0.03% 664
2018
Q1
$15.4M Buy
94,961
+6,867
+8% +$1.09M 0.03% 647
2017
Q4
$12.9M Buy
88,094
+5,890
+7% +$839K 0.03% 683
2017
Q3
$11.2M Buy
82,204
+1,637
+2% +$207K 0.03% 706
2017
Q2
$10.1M Buy
80,567
+9,601
+14% +$1.15M 0.02% 701
2017
Q1
$8.43M Buy
70,966
+9,602
+16% +$1.15M 0.02% 718
2016
Q4
$7.08M Buy
61,364
+9,214
+18% +$1.03M 0.02% 731
2016
Q3
$5.45M Buy
52,150
+16,524
+46% +$1.72M 0.02% 751
2016
Q2
$3.47M Buy
35,626
+5,960
+20% +$563K 0.01% 615
2016
Q1
$2.85M Sell
29,666
-525
-2% -$47.8K 0.01% 636
2015
Q4
$2.73M Buy
30,191
+8,779
+41% +$826K 0.01% 621
2015
Q3
$1.99M Buy
21,412
+1,334
+7% +$127K 0.01% 634
2015
Q2
$1.87M Buy
20,078
+18,718
+1,376% +$1.75M 0.01% 652
2015
Q1
$129K Sell
1,360
-35,572
-96% -$3.3M ﹤0.01% 802
2014
Q4
$3.27M Sell
36,932
-3,818
-9% -$324K 0.01% 589
2014
Q3
$3.26M Sell
40,750
-5,162
-11% -$389K 0.02% 380
2014
Q2
$3.26M Sell
45,912
-605,339
-93% -$42.6M 0.02% 388
2014
Q1
$48.2M Buy
651,251
+300,296
+86% +$22.7M 0.33% 104
2013
Q4
$27.5M Sell
350,955
-145,576
-29% -$11.4M 0.19% 192
2013
Q3
$36.7M Buy
+496,531
New +$36.6M 0.26% 126

Other funds holding CME

Victory Capital Management's CME Position: Q1 2026 in Review

Victory Capital Management reduced its CME Group (CME) stake by 53% in Q1 2026, selling an estimated $322M and leaving 964,043 shares worth $285M. The position accounts for 0.18% of the portfolio, ranked #138.

Victory Capital Management first reported a position in CME in Q3 2013 and has held it in 51 quarters since. The position peaked at $560M in Q4 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Victory Capital Management held 964,043 shares of CME Group worth $285M as of Q1 2026.
  • Victory Capital Management sold 1,085,606 CME Group shares in Q1 2026, an estimated $322M.
  • CME Group made up 0.18% of Victory Capital Management's portfolio in Q1 2026, its #138 holding.
  • Victory Capital Management first reported a position in CME Group in Q3 2013 and has held it in 51 quarters since.
  • Victory Capital Management's CME Group position peaked at $560M in Q4 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.